Skip to content
OpenCapital
Get started

Emergent Biosolutions EBS Market capitalization

Market capitalization at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$182.6B-2.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$81.68B+17.8%
AMP
Amphastar PharmaceuticalsAMPH
$888.8M-35.7%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$3.97B+51.0%
CorMedix logo
CorMedixCRMD
$536.75M+33.7%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$1.05B+9.5%

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Enterprise value$834.84M-2.6%
P/E3.6×—
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%—

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Computed from the period-end share price: $428.65M.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's market capitalization?
Emergent Biosolutions (EBS) reported market capitalization of $428.65M in Q1 2026.
How has Emergent Biosolutions's market capitalization changed year-over-year?
Emergent Biosolutions's market capitalization increased by 62.3% year-over-year, from $264.08M to $428.65M.
What is the long-term trend for Emergent Biosolutions's market capitalization?
Over 5 years (2020 to 2025), Emergent Biosolutions's market capitalization has grown at a -33.0% compound annual growth rate (CAGR), from $4.82B to $649.15M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.